Turkish Journal of Nephrology
Editorial

Are Your Kidneys Ok? Detect Early to Protect Kidney Health

1.

Mount Sinai Hospital, Department of Medicine-Renal Medicine, New York, New York, USA National Kidney Foundation, Inc., New York, USA

2.

Queensland Children’s Hospital, Department of Nephrology, South Brisbane, Queensland, Australia

3.

Faculdade Ciencias Medicas de Minas Gerais, Brazil, Hospital das Clinicas, Ebserh, Universidade Federal de Minas Gerais, Brazil

4.

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

5.

Department of Nephrology, Cairo University Hospital, Cairo, Egypt

6.

Renal Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA

7.

Second Department of Nephrology, AHEPA University Hospital Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece

8.

Nephrology Department, Péterfy Hospital, Budapest, Hungary

9.

Tamilnad Kidney Research (TANKER) Foundation, Chennai, India

10.

Division of Health System, Policy and Management, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong

11.

Italian Kidney Foundation, Rome, Italy

Turkish J Nephrol 2025; 34: 71-78
DOI: 10.5152//turkjnephrol.2025.25032425
Read: 490 Downloads: 458 Published: 15 April 2025

Early identification of kidney disease can protect kidney health, prevent kidney disease progression and related complications, reduce cardiovascular disease risk, and decrease mortality. One must ask, “Are your kidneys ok?” using serum creatinine to estimate kidney function and urine albumin to assess for kidney and endothelial damage. Evaluation for causes and risk factors for chronic kidney disease (CKD) includes testing for diabetes and measurement of blood pressure and body mass index. This World Kidney Day, the authors assert that case-finding in high-risk populations, or even populationlevel screening, can decrease the burden of kidney disease globally. Early-stage CKD is asymptomatic, simple to test for, and recent paradigm-shifting CKD treatments such as sodium glucose co-transporter-2 inhibitors dramatically improve outcomes and favor the cost-benefit analysis for screening or case-finding programs. Despite this, numerous barriers exist, including resource allocation, healthcare funding, healthcare infrastructure, and healthcare-professional and population awareness of kidney disease. Coordinated efforts by major kidney non-governmental organizations to prioritize the kidney health agenda for governments and align early detection efforts with other current programs will maximize efficiencies.

Cite this article as: Vassalotti JA, Francis A, Cesar Soares Dos Santos A, et al. Are your kidneys ok? Detect early to protect kidney health. Turk J Nephrol. 2025;34(2):71-78.

Files
EISSN 2667-4440